Roger Kuypers has over 20 years’ experience as a lawyer, director and investor in the life sciences sector. His experience includes working in the biotech, medical device, diagnostics and functional foods fields. Roger has worked with start-up companies, large pharmaceutical companies, universities, centers of excellence and health authorities. Roger provides legal services in respect of a broad scope of life sciences activities, including pre-clinical and clinical research, licensing, finance and intellectual property.
On the business side, Roger has served and continues to serve on a number of corporate boards of biotech and medical device companies. On the biotech side, he served over 10 years as a director of KMT Hepatech Inc., which provides compound and vaccine testing services using its proprietary chimeric animal model. He also served as a Chairman of a local reagent and biotech company, helping to launch its translational research facilities in India. He currently serves on the boards of two BC medical device companies.
Roger also brings a broad geographic perspective to the table, being called to the British Columbia and Alberta bars. Roger practiced with Dentons in Edmonton for five years before returning to Vancouver, during which he worked closely with the Alberta life sciences community. He established the clinical trial agreement review and negotiation system for the Northern Alberta Clinical Trials and Research Centre at the University of Alberta. Roger has also acted for foreign clients, including Takeda Pharmaceutical Company of Japan.
On the community side, Roger has served as a director of BC Medtech (prior to its merger with Lifesciences BC) and the BC Clinical Research Infrastructure Network (BCCRIN). He has hosted the Speaker Series of the Clinical Research Professionals of BC for the last 17 years and is a regular presenter on legal issues in clinical research.